Molecular Cancer Therapeutics Molecular Diagnostics in Cancer Therapeutic Development: Fulfilling the Promise of Personalized Medicine Bridging the Lab and the Clinic in Cancer Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Green, S. K.
Right arrow Articles by Kerbel, R. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Green, S. K.
Right arrow Articles by Kerbel, R. S.
Mol Cancer Ther. 2004;3:149-159
© 2004 American Association for Cancer Research

Antiadhesive antibodies targeting E-cadherin sensitize multicellular tumor spheroids to chemotherapy in vitro

Shane K. Green1, Giulio Francia1, Ciro Isidoro2 and Robert S. Kerbel1

1 Molecular and Cellular Biology Research, Sunnybrook and Women's College Health Sciences Center and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada and 2 Laboratory of Molecular Pathology, Department of Medical Sciences, "Amedeo Avogadro" University, Novara, Italy

Requests for Reprints:Robert S. Kerbel, Molecular and Cellular Biology Research, Sunnybrook and Women's College Health Sciences Center, Research Building, S-217, 2075 Bayview Avenue, Toronto, ON, Canada M4N 3M5. Phone: (416) 480-5711; Fax: (416) 480-5884. E-mail: robert.kerbel{at}swchsc.on.ca

Multicellular resistance, a subtype of therapeutic resistance manifested in cancer cells grown as three-dimensional multicellular masses, such as spheroids in vitro and solid tumors in vivo, occurs with respect to a variety of anticancer treatment strategies including chemotherapy, ionizing radiation, and even host-mediated antibody-dependent cellular cytotoxicity. Previous studies from our laboratory have shown that multicellular resistance to chemotherapy demonstrated by aggregates of EMT-6 murine mammary carcinoma cells can be overcome by using hyaluronidase to disrupt intercellular adhesive interactions and associated patterns of protein expression. In this proof of principle study, we explored the concept of antiadhesive chemosensitization in the context of human cancer cells by using a monoclonal antibody to disrupt E-cadherin-mediated cell-cell interactions in multicellular spheroids of HT29 human colorectal adenocarcinoma. In so doing, we found that disruption of E-cadherin-mediated adhesion sensitizes multicellular spheroids of HT29 in vitro to treatment with 5-fluorouracil, paclitaxel, vinblastine, and etoposide but not cisplatin. Furthermore, we have found that antibody-mediated blockage of E-cadherin function leads to decreased expression and activity of protein kinase C {alpha} and ß1, both of which have previously been implicated in chemoresistance exhibited by HT29 cells; however, we have found that the chemosensitization effects of the anti-E-cadherin antibody are independent of its influence on protein kinase C ß1.


Grant support:National Cancer Institute of Canada (R. S. Kerbel) no. 11283; Natural Sciences and Engineering Research Council of Canada PGSA and PGSB studentships and Ontario Graduate Scholarship for Science and Technology, Government of Ontario, Canada (S. K. Green).

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

3 G. Francia, et al. Gene expression analysis of multicellular tumor spheroids reveals a role for suppressed DNA mismatch repair in resistance to alkylating agents, manuscript in preparation.

Received 7/11/03; revised 10/ 8/03; accepted 11/ 3/03.




This article has been cited by other articles:


Home page
Cancer Res.Home page
C. C. Park, H. Zhang, M. Pallavicini, J. W. Gray, F. Baehner, C. J. Park, and M. J. Bissell
{beta}1 Integrin Inhibitory Antibody Induces Apoptosis of Breast Cancer Cells, Inhibits Growth, and Distinguishes Malignant from Normal Phenotype in Three Dimensional Cultures and In vivo
Cancer Res., February 1, 2006; 66(3): 1526 - 1535.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
W. Zhang, A. Alt-Holland, A. Margulis, Y. Shamis, N. E. Fusenig, U. Rodeck, and J. A. Garlick
E-cadherin loss promotes the initiation of squamous cell carcinoma invasion through modulation of integrin-mediated adhesion
J. Cell Sci., January 15, 2006; 119(2): 283 - 291.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. Francia, S. K. Green, G. Bocci, S. Man, U. Emmenegger, J. M.L. Ebos, A. Weinerman, Y. Shaked, and R. S. Kerbel
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agents
Mol. Cancer Ther., October 1, 2005; 4(10): 1484 - 1494.
[Abstract] [Full Text] [PDF]


Home page
aacredbookHome page
G. Francia, S. Green, and R. S. Kerbel
Epigenetic Aspects of Environmentally Mediated "Multicellular" Drug Resistance
Am. Assoc. Cancer Res. Educ. Book, April 1, 2005; 2005(1): 114 - 118.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.